Advertisement
Biological Psychiatry
Advanced SearchSave search
Abstract only| Volume 85, ISSUE 10, SUPPLEMENT , S126, May 15, 2019

O50. Efficacy and Safety of an Asenapine Transdermal Patch (Asenapine Transdermal System, HP-3070) in the Treatment of Adults With Schizophrenia: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 6-Week Inpatient Study

DOI:https://doi.org/10.1016/j.biopsych.2019.03.315
O50. Efficacy and Safety of an Asenapine Transdermal Patch (Asenapine Transdermal System, HP-3070) in the Treatment of Adults With Schizophrenia: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 6-Week Inpatient Study
Previous ArticleO49. Ketamine Promotes Fear Extinction and Rescues Dysfunction of Glutamate Release in a Rat Model of PTSD
Next ArticleO51. Beyond C4: Analysis of the Complement Gene Pathway Shows Enrichment for IQ in Patients With Schizophrenia and Healthy Controls
      HP-3070, a once-daily asenapine transdermal patch for schizophrenia, offers favorable pharmacokinetics.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      Article Info

      Identification

      DOI: https://doi.org/10.1016/j.biopsych.2019.03.315

      Copyright

      © 2019 Published by Elsevier Inc.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2022 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX